Medtronic (NYSE:MDT) Canada announced today that Health Canada granted a license to its MiniMed 780G automated insulin delivery system.
The company designed its MiniMed 780G advanced hybrid closed-loop insulin pump system to automatically adjust and correct sugars every five minutes. According to Medtronic, it marks the first and only insulin pump system in Canada to do so. It also features SmartGuard technology for avoiding highs and lows in blood sugar.
SmartGuard enables users to personalize their glucose goals with an adjustable target setting. The setting — as low as 5.5 mmol/L — comes in lower than any other advanced hybrid closed-loop system, Medtronic said. It helps stabilize blood sugar levels to further improve glucose control.
Get the full story at our sister site, Drug Delivery Business News.